兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06622 兆科眼科-B

开市前 11-19 09:24:43

1.360

+0.000

0.00%

最高1.360	最低1.360	成交量0.00
今开1.360	昨收1.360	日振幅0.00%
总市值7.43亿	流通市值7.43亿	总股本5.46亿
成交额0.00	换手率0.00%	流通股本5.46亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06622","market":"HK","secType":"STK","nameCN":"兆科眼科-B","latestPrice":1.36,"timestamp":1731978002057,"preClose":1.36,"halted":0,"volume":0,"delay":0,"floatShares":546139172,"shares":546139172,"eps":-0.7620424,"marketStatus":"开市前","marketStatusCode":1,"change":0,"latestTime":"11-19 09:24:43","open":1.36,"high":1.36,"low":1.36,"amount":0,"amplitude":0,"askPrice":1.4,"askSize":14000,"bidPrice":1.33,"bidSize":30000,"shortable":0,"etf":0,"ttmEps":-0.4518563110149507,"exchange":"SEHK","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"listingDate":1619625600000,"adjPreClose":1.36,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06622/tweets","defaultTab":"tweets","newsList":[{"id":"2483367803","title":"李氏大药厂盘中异动 早盘股价大跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483367803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483367803?lang=zh_cn&edition=full","pubTime":"2024-11-15 10:00","pubTimestamp":1731636053,"startTime":"0","endTime":"0","summary":"2024年11月15日早盘10时00分，李氏大药厂股票出现波动，股价快速下跌6.25%。截至发稿，该股报1.200港元/股，成交量5万股，换手率0.01%，振幅1.56%。资金方面，该股资金流入0港元，流出6.032万港元。李氏大药厂股票所在的药品行业中，整体跌幅为0.16%。其相关个股中，开拓药业-B、中国生物制药、雅各臣科研制药涨幅较大，振幅较大的相关个股有开拓药业-B、先声药业、康臣药业，振幅分别为8.70%、8.01%、4.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111510005398e42c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111510005398e42c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1587","BK1583","BK1574","06622","BK1191"],"gpt_icon":0},{"id":"2483367189","title":"李氏大药厂(00950)股价下跌5.469%，现价港币$1.21","url":"https://stock-news.laohu8.com/highlight/detail?id=2483367189","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483367189?lang=zh_cn&edition=full","pubTime":"2024-11-15 10:00","pubTimestamp":1731636000,"startTime":"0","endTime":"0","summary":"[下跌股]李氏大药厂(00950) 股价在上午10:00比前收市价下跌5.469%，现股价为港币$1.21。至目前为止，今日最高价为$1.22，而最低价为$1.21。总成交量为3.1万股，总成交金额为港币$3.751万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD241115589/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","00950","BK1191","06622","BK1574","BK1587"],"gpt_icon":0},{"id":"2482303410","title":"业绩向好、股价遇冷，兆科眼科-B(06622)为何“叫好不叫座”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2482303410","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482303410?lang=zh_cn&edition=full","pubTime":"2024-11-09 16:55","pubTimestamp":1731142516,"startTime":"0","endTime":"0","summary":"然而，创新药板块一片飘红之际，却有一家创新药企任凭投资者“千呼万唤”，股价也迟迟不见上涨，那就是兆科眼科-B。目前兆科眼科已向监管部门提交了NVK002的上市申请，其有望成为国内第二款低浓度阿托品药物，抢占巨大的潜在市场。利好带来高预期的同时，2024年上半年兆科眼科也出现营收、利润双双显著改善。不过与行业回暖、业绩向好截然相反的是，兆科眼科的股价却一路下行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06622","BK1191","BK1587","BK1583"],"gpt_icon":0},{"id":"2481143940","title":"兆科眼科-B盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481143940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481143940?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:21","pubTimestamp":1730964062,"startTime":"0","endTime":"0","summary":"2024年11月07日下午盘15时21分，兆科眼科-B股票出现异动，股价快速上涨5.04%。兆科眼科-B股票所在的药品行业中，整体跌幅为0.03%。其相关个股中，雅各臣科研制药、兆科眼科-B、德琪医药-B涨幅较大，振幅较大的相关个股有中生联合、雅各臣科研制药、顺腾国际控股，振幅分别为22.22%、11.76%、10.71%。兆科眼科-B公司简介：兆科眼科有限公司是一家主要从事眼科药物开发、制造及营销业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152103a21f7ec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152103a21f7ec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1587","BK1191","06622"],"gpt_icon":0},{"id":"2481292858","title":"兆科眼科－Ｂ(06622)股价上升5.036%，现价港币$1.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2481292858","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481292858?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:20","pubTimestamp":1730964000,"startTime":"0","endTime":"0","summary":"[上升股]兆科眼科－Ｂ(06622) 股价在下午03:20比前收市价上升5.036%，现股价为港币$1.46。至目前为止，今日最高价为$1.46，而最低价为$1.38。总成交量为31.05万股，总成交金额为港币$44.23万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411075192/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","06622","BK1191","BK1587","BK1583"],"gpt_icon":0},{"id":"2480040530","title":"李氏大药厂盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480040530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480040530?lang=zh_cn&edition=full","pubTime":"2024-11-01 13:00","pubTimestamp":1730437205,"startTime":"0","endTime":"0","summary":"2024年11月01日下午盘13时00分，李氏大药厂股票出现异动，股价快速拉升5.00%。截至发稿，该股报1.260港元/股，成交量6500股，换手率0.00%，振幅4.17%。李氏大药厂股票所在的药品行业中，整体涨幅为0.12%。其相关个股中，顺腾国际控股、艾美疫苗、衍生集团涨幅较大，振幅较大的相关个股有顺腾国际控股、中生联合、三爱健康集团，振幅分别为88.89%、12.90%、10.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101130005971a3bf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101130005971a3bf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","00950","BK1574","BK1191","06622"],"gpt_icon":1},{"id":"2477482165","title":"兆科眼科逆市涨逾8.8% 核心产品NVK002治疗近视加深试验溶液患者使用依从性好","url":"https://stock-news.laohu8.com/highlight/detail?id=2477482165","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477482165?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:11","pubTimestamp":1729735915,"startTime":"0","endTime":"0","summary":"金吾财讯 | 兆科眼科(06622)早盘股价逆市走高，最高曾见1.62港元，涨超19%，最新报1.48港元，仍涨8.82%，成交额422.65万港元。消息面上，公司发布NVK002为期两年的第III期临床试验（China CHAMP）的顶线结果。经过两年的治疗，这项研究分析显示，NVK002滴眼液组（0.01%和0.02%剂量）对比安慰剂组在主要疗效指标上有统计学意义的显着性差异，NVK002滴眼液组优于安慰剂组，且具有剂量依赖。两种剂量的NVK002安全性良好，患者使用依从性好。NVK002是一种用于控制儿童及青少年近视加深的试验性新型外用眼部溶液。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024101212ab6ec600&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024101212ab6ec600&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06622","BK1583","BK1574","BK1587"],"gpt_icon":0},{"id":"2477051778","title":"兆科眼科-B早盘涨超9% NVK002近视治疗临床试验显积极效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2477051778","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477051778?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:03","pubTimestamp":1729735380,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　兆科眼科-B（06622）早盘高开，股价上涨9.56%，现报1.49港元，成交额417.29万港元。\n　　兆科眼科-B发布公告，NVK002（公司核心产品之一）为期两年的第III期临床试验的顶线结果。经过两年的治疗，这项研究分析显示，NVK002滴眼液组（0.01%和0.02%剂量）对比安慰剂组在主要疗效指标上有统计学意义的显著性差异，NVK002滴眼液组优于安慰剂组，且具有剂量依赖。两种剂量的NVK002安全性良好，患者使用依从性好。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-10-24/doc-inctrisz9960151.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-10-24/doc-inctrisz9960151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1587","BK1141","03347","BK1576","BK1191","BK1583","BK1574","06622"],"gpt_icon":0},{"id":"2477551772","title":"兆科眼科-B(06622)上涨9.56%，报1.49元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477551772","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477551772?lang=zh_cn&edition=full","pubTime":"2024-10-24 09:57","pubTimestamp":1729735060,"startTime":"0","endTime":"0","summary":"10月24日，兆科眼科-B(06622)盘中上涨9.56%，截至09:57，报1.49元/股，成交410.81万元。兆科眼科有限公司是一家致力于眼科疗法的研发、生产和商业化的领先制药企业，其产品覆盖了6种主要的眼科适应症，并由广州南沙的先进生产设施制造。公司的目标是通过科研改善中国大众的视力健康，实现产品的商业化，并以与国内外制药公司的合作，努力成为世界眼科领域的领导者。截至2024年中报，兆科眼科-B营业总收入4976.9万元、净利润-7580.2万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/24095744374482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06622","BK1587","BK1583","BK1574","BK1191"],"gpt_icon":0},{"id":"2477451266","title":"兆科眼科-B股价上涨10.29% 市值涨8429.67万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477451266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477451266?lang=zh_cn&edition=full","pubTime":"2024-10-24 09:30","pubTimestamp":1729733409,"startTime":"0","endTime":"0","summary":"2024年10月24日早盘09时30分，兆科眼科-B股票出现异动，股价急速拉升10.29%。截至发稿，该股报1.500港元/股，成交量39.75万股，换手率0.07%，振幅2.94%。资金方面，该股资金流入15.8885万港元，流出12.651万港元。兆科眼科-B股票所在的药品行业中，整体涨幅为0.00%。其相关个股中，兆科眼科-B、艾美疫苗、复星医药涨幅较大，振幅较大的相关个股有兆科眼科-B、翰森制药、艾美疫苗，振幅分别为2.94%、1.94%、1.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024093010971a1e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024093010971a1e58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06622","BK1191","BK1587","BK1583"],"gpt_icon":0},{"id":"2477511097","title":"港股异动 | 兆科眼科-B(06622)高开逾9% NVK002近视治疗临床试验显积极效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2477511097","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477511097?lang=zh_cn&edition=full","pubTime":"2024-10-24 09:24","pubTimestamp":1729733074,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兆科眼科-B高开逾9%，截至发稿，涨9.56%，报1.49港元，成交额22.13万港元。消息面上，兆科眼科-B发布公告，NVK002为期两年的第III期临床试验的顶线结果。经过两年的治疗，这项研究分析显示，NVK002滴眼液组对比安慰剂组在主要疗效指标上有统计学意义的显著性差异，NVK002滴眼液组优于安慰剂组，且具有剂量依赖。两种剂量的NVK002安全性良好，患者使用依从性好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1583","BK1574","06622","BK1191","BK1141","BK1576","03347"],"gpt_icon":0},{"id":"2477259793","title":"智通港股早知道 | 国资委提出超前布局量子科技、核聚变、生物制造、6G等未来产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2477259793","media":"智通财经","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477259793?lang=zh_cn&edition=full","pubTime":"2024-10-24 07:25","pubTimestamp":1729725942,"startTime":"0","endTime":"0","summary":"国资委：超前布局、梯次培育量子科技、核聚变、生物制造、6G等未来产业国务院国资委网站10月23日消息，《党建研究》日前刊发国务院国资委党委署名文章称，加快培育壮大战略性新兴产业和未来产业。值得注意的是，此次下调价格的生产企业均隶属于国药集团中国生物旗下。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1556","BK1574","BK1589","BK1521","03301","SG9999001069.SGD","LU0039217434.USD","LU0307460666.USD","00981","BK1172","01928","02202","09992","LU0531971595.HKD","03690","BK1587","02460","BK1596","HSCEI","LU0251144936.SGD","BK1519","SG9999001051.SGD","HSTECH","00175","00700","00605","SG9999006597.SGD","LU0048597586.USD","09901","09988","01211","02318","SG9999002950.SGD","LU0651946864.USD","BK1588","LU0871576103.HKD","00388","BK1228","06622","IE0034224299.USD","BK1191","LU1211504680.USD","09618","SG9999001093.SGD","03908","BK1583","06030","LU1051768304.USD","LU1515016050.SGD","YANG","02269","01347","LU0164865239.USD","01918","LU0588546209.SGD"],"gpt_icon":1},{"id":"2477467309","title":"兆科眼科(06622.HK)NVK002中国第III期临床试验取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2477467309","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477467309?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:50","pubTimestamp":1729677000,"startTime":"0","endTime":"0","summary":"兆科眼科-B(06622.HK) 公布，公司核心产品之一NVK002为期两年的第III期临床试验的顶线结果显示，NVK002滴眼液组对比安慰剂组在主要疗效指标上有统计学意义的显著性差异，NVK002滴眼液组优于安慰剂组，而且具有剂量依赖。两种剂量的NVK002安全性良好，患者使用依从性好。公司指，临床试验主要目标为评估NVK002对治疗内地儿童及青少年近视加深的疗效及安全性。该项试验涉及18间中心，入组777名患者。(vc/a)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210624120657847_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210624120657847_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1390505/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06622","BK1587","BK1583","BK1141","03347","BK1574","BK1191","BK1576"],"gpt_icon":0},{"id":"2477306338","title":"兆科眼科-B(06622)：用于治疗儿童近视加深的NVK002为期两年的中国第III期临床试验(CHINA CHAMP)的积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2477306338","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477306338?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:46","pubTimestamp":1729676818,"startTime":"0","endTime":"0","summary":"智通财经APP讯，兆科眼科-B 发布公告，NVK002为期两年的第III期临床试验的顶线结果。经过两年的治疗，这项研究分析显示，NVK002滴眼液组对比安慰剂组在主要疗效指标上有统计学意义的显著性差异，NVK002滴眼液组优于安慰剂组，且具有剂量依赖。两种剂量的NVK002安全性良好，患者使用依从性好。该项试验涉及18间中心，入组777名患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK4134","BK1576","BK1583","BK1141","03347","III","06622","BK1191","BK1574"],"gpt_icon":0},{"id":"2477114000","title":"兆科眼科-B(06622)下跌5.15%，报1.29元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477114000","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477114000?lang=zh_cn&edition=full","pubTime":"2024-10-21 14:21","pubTimestamp":1729491673,"startTime":"0","endTime":"0","summary":"10月21日，兆科眼科-B(06622)盘中下跌5.15%，截至14:21，报1.29元/股，成交120.21万元。兆科眼科有限公司是一家致力于眼科疗法的研发、生产和商业化的领先制药企业，其产品覆盖了6种主要的眼科适应症，并由广州南沙的先进生产设施制造。公司的目标是通过科研改善中国大众的视力健康，实现产品的商业化，并以与国内外制药公司的合作，努力成为世界眼科领域的领导者。截至2024年中报，兆科眼科-B营业总收入4976.9万元、净利润-7580.2万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/21142144232391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1587","BK1583","BK1191","BK1574","06622"],"gpt_icon":0},{"id":"2477002085","title":"兆科眼科-B盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477002085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477002085?lang=zh_cn&edition=full","pubTime":"2024-10-21 14:20","pubTimestamp":1729491608,"startTime":"0","endTime":"0","summary":"2024年10月21日下午盘14时20分，兆科眼科-B股票出现波动，股价急速跳水5.15%。截至发稿，该股报1.290港元/股，成交量90.15万股，换手率0.17%，振幅5.15%。兆科眼科-B股票所在的药品行业中，整体跌幅为0.27%。其相关个股中，三爱健康集团、顺腾国际控股、中生联合涨幅较大，振幅较大的相关个股有三爱健康集团、联康生物科技集团、顺腾国际控股，振幅分别为18.03%、13.85%、11.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021142008971a1507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021142008971a1507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1583","06622","BK1191"],"gpt_icon":0},{"id":"2477000896","title":"兆科眼科－Ｂ(06622)股价下跌5.147%，现价港币$1.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2477000896","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477000896?lang=zh_cn&edition=full","pubTime":"2024-10-21 14:20","pubTimestamp":1729491600,"startTime":"0","endTime":"0","summary":"[下跌股]兆科眼科－Ｂ(06622) 股价在下午02:20比前收市价下跌5.147%，现股价为港币$1.29。至目前为止，今日最高价为$1.36，而最低价为$1.29。总成交量为90.15万股，总成交金额为港币$118.912万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2410211623/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06622","BK1583","BK1587","BK1574","BK1191"],"gpt_icon":0},{"id":"2475655514","title":"兆科眼科-B盘中异动 股价大跌5.33%报1.420港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475655514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475655514?lang=zh_cn&edition=full","pubTime":"2024-10-15 13:18","pubTimestamp":1728969480,"startTime":"0","endTime":"0","summary":"2024年10月15日下午盘13时18分，兆科眼科-B股票出现异动，股价急速跳水5.33%。截至发稿，该股报1.420港元/股，成交量30.35万股，换手率0.06%，振幅3.33%。资金方面，该股资金流入5.944万港元，流出37.591万港元。兆科眼科-B股票所在的药品行业中，整体跌幅为0.16%。其相关个股中，康臣药业、泰凌医药、海王英特龙涨幅较大，振幅较大的相关个股有华控康泰、泰凌医药、中生联合，振幅分别为25.00%、11.58%、11.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015131801971a0458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015131801971a0458&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1583","06622","BK1191"],"gpt_icon":0},{"id":"2475326727","title":"李氏大药厂：重组安菲博肽注射液临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2475326727","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475326727?lang=zh_cn&edition=full","pubTime":"2024-10-15 08:03","pubTimestamp":1728950615,"startTime":"0","endTime":"0","summary":"李氏大药厂（00950）公布，于2024年9月 25日，中国国家药品监督管理局受理重组安菲博肽注射液临床试验申请，受理号CXSL2400638、CXSL2400639。本次为该品首次临床试验注册申报，提交临床方案包括I期（单次给药和多次给药）以及II期临床方案。\n　　重组安菲博肽注射液为一种由该集团全资附属公司兆科药业（合肥）有限公司发现及拥有的一类治疗用生物制品，符合中国国家药监局发布的药品生产品质管制规范。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-15/doc-incsqtkf1021853.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-15/doc-incsqtkf1021853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1191","BK1587","00950","03347","06622","BK1574","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2475367653","title":"李氏大药厂：重组安菲博肽注射液或获得临床试验药物申请受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2475367653","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475367653?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:50","pubTimestamp":1728913802,"startTime":"0","endTime":"0","summary":"格隆汇10月14日丨李氏大药厂公告，于2024年9月25日，中国国家药品监督管理局受理重组安菲博肽注射液临床试验申请，受理号CXSL2400638、CXSL2400639。重组安菲博肽注射液为一种由集团全资附属公司兆科药业(合肥)有限公司发现及拥有的一类治疗用生物制品，符合中国国家药监局发布的药品生产品质管制规范。本集团拥有该药物全球知识产权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421500995a7529a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421500995a7529a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","00950","BK1587","BK1191","06622","BK1141","BK1574","BK1583","03347"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0685},{"period":"1month","weight":0},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.1282},{"period":"1year","weight":-0.68},{"period":"ytd","weight":-0.6557}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"兆科眼科有限公司是一家主要从事眼科药物的开发、制造及销售业务的中国公司。该公司的眼科药物包括创新药和仿制药。该公司的产品主要用于五大眼科适应症，包括干眼症、湿性老年黄斑部病变、糖尿病黄斑水肿、近视及青光眼。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.111455},{"month":2,"riseRate":0,"avgChangeRate":-0.24555},{"month":3,"riseRate":0,"avgChangeRate":-0.100541},{"month":4,"riseRate":0.333333,"avgChangeRate":0.082275},{"month":5,"riseRate":0.25,"avgChangeRate":-0.097972},{"month":6,"riseRate":0.25,"avgChangeRate":0.066102},{"month":7,"riseRate":0.25,"avgChangeRate":-0.106219},{"month":8,"riseRate":0,"avgChangeRate":-0.064675},{"month":9,"riseRate":0.5,"avgChangeRate":-0.002156},{"month":10,"riseRate":0.25,"avgChangeRate":-0.065946},{"month":11,"riseRate":0.25,"avgChangeRate":0.018938},{"month":12,"riseRate":0.333333,"avgChangeRate":0.04653}],"exchange":"SEHK","name":"兆科眼科-B","nameEN":"ZHAOKE OPHTH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兆科眼科-B,06622,兆科眼科-B股票,兆科眼科-B股票老虎,兆科眼科-B股票老虎国际,兆科眼科-B行情,兆科眼科-B股票行情,兆科眼科-B股价,兆科眼科-B股市,兆科眼科-B股票价格,兆科眼科-B股票交易,兆科眼科-B股票购买,兆科眼科-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}